Updated Jul 16, 2026
Cole G Bradley has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $211K.

Cole G. Bradley is a director at Castle Biosciences Inc., a company focused on providing innovative diagnostic tests and services to improve the treatment of cancer. His role involves overseeing the company's strategic direction and governance.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 2.8K | — | |
| 2026-05-27 | CSTL | CASTLE BIOSCIENCES INC | M — Option exercise | 13.7K | — | |
| 2026-03-09 | CSTL | CASTLE BIOSCIENCES INC | S — Open-market sale | 2.7K | $28.51 | $76K |
| 2026-03-09 | CSTL | CASTLE BIOSCIENCES INC | S — Open-market sale | 4.7K | $28.44 | $135K |
| 2026-03-09 | CSTL | CASTLE BIOSCIENCES INC | M — Option exercise | 4.7K | $3.38 | $16K |
Cole G. Bradley is a director at Castle Biosciences Inc., a company focused on providing innovative diagnostic tests and services to improve the treatment of cancer. His role involves overseeing the company's strategic direction and governance.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($211K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cole G Bradley profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.